These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 15584374)
21. New anxiolytics in development. Mosconi M; Chiamulera C; Recchia G Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335 [TBL] [Abstract][Full Text] [Related]
22. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba]. Tsuji M; Miyagawa K; Takeuchi T; Takeda H Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of anxiolytic potential of Celastrus oil in rat models of behaviour. Rajkumar R; Kumar EP; Sudha S; Suresh B Fitoterapia; 2007 Feb; 78(2):120-4. PubMed ID: 17169502 [TBL] [Abstract][Full Text] [Related]
24. Anxioselective anxiolytics: can less be more? Basile AS; Lippa AS; Skolnick P Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051 [TBL] [Abstract][Full Text] [Related]
25. Recent developments in anxiety disorders. Christmas DM; Hood SD Recent Pat CNS Drug Discov; 2006 Nov; 1(3):289-98. PubMed ID: 18221210 [TBL] [Abstract][Full Text] [Related]
26. Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator. Lippa A; Czobor P; Stark J; Beer B; Kostakis E; Gravielle M; Bandyopadhyay S; Russek SJ; Gibbs TT; Farb DH; Skolnick P Proc Natl Acad Sci U S A; 2005 May; 102(20):7380-5. PubMed ID: 15870187 [TBL] [Abstract][Full Text] [Related]
27. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Awad R; Arnason JT; Trudeau V; Bergeron C; Budzinski JW; Foster BC; Merali Z Phytomedicine; 2003 Nov; 10(8):640-9. PubMed ID: 14692724 [TBL] [Abstract][Full Text] [Related]
28. New molecular targets for antianxiety interventions. Gorman JM J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131 [TBL] [Abstract][Full Text] [Related]
29. Anxiolytics not acting at the benzodiazepine receptor: beta blockers. Tyrer P Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):17-26. PubMed ID: 1348368 [TBL] [Abstract][Full Text] [Related]
36. Approaches to developing new anxiolytics and antidepressants. Dubovsky SL J Clin Psychiatry; 1993 May; 54 Suppl():75-83. PubMed ID: 8099580 [TBL] [Abstract][Full Text] [Related]
37. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test. Rezvanfard M; Zarrindast MR; Bina P Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194 [TBL] [Abstract][Full Text] [Related]
38. Benzodiazepines as anxiolytic agents: the risks of long-term treatment. Mackler SA; Schweizer E Hosp Pract (Off Ed); 1992 Sep; 27(9A):109-12, 115-6. PubMed ID: 1355775 [No Abstract] [Full Text] [Related]
39. [Study in pediatrics of an anxiolytic drug: clobazam]. Guran P Ann Pediatr (Paris); 1976 Jun; 23(6-7):489-91. PubMed ID: 16104205 [No Abstract] [Full Text] [Related]
40. GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Pilc A; Nowak G Drugs Today (Barc); 2005 Nov; 41(11):755-66. PubMed ID: 16395415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]